Therapy of early chronic phase chronic myelogenous leukemia (CML) with alpha interferon (IFN-A), low-dose cytosine arabinoside (ARA-C), and homoharringtonine (HHT) [omacetaxine mepesuccinate]
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cytarabine; Interferon alpha; Omacetaxine mepesuccinate
- Indications Chronic myeloid leukaemia
- Focus Therapeutic Use
- 30 Jul 2012 Biomarkers information updated
- 10 Sep 2005 New trial record.